These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11200612)

  • 1. [Lipid profiles in peritoneal dialysis].
    Pagniez D
    Nephrologie; 2000; 21(7):361-2. PubMed ID: 11200612
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of dialysis membranes on lipid parameters].
    de Précigout V
    Nephrologie; 2000; 21(7):359-60. PubMed ID: 11200611
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing a peritoneal dialysis patient with high risk for cardiovascular disease.
    Pecoits-Filho R
    Nephron Clin Pract; 2010; 116(4):c283-8. PubMed ID: 20639674
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.
    Van Biesen W; Verbeke F; Vanholder R
    Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid disturbances in chronic renal failure--patomechanisms and treatment.
    Rutkowski B; Chmielewski M
    Rocz Akad Med Bialymst; 2004; 49():139-44. PubMed ID: 15631330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of simvastatin in patients undergoing chronic renal dialysis: are we ready to treat hypercholesterolemia?
    Masterson TM
    Am J Kidney Dis; 2002 Feb; 39(2):419-21. PubMed ID: 11840386
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis.
    Segall L; Covic A
    Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221
    [No Abstract]   [Full Text] [Related]  

  • 8. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients.
    Steiner S; Schaller G; Puttinger H; Födinger M; Kopp CW; Seidinger D; Grisar J; Hörl WH; Minar E; Vychytil A; Wolzt M; Sunder-Plassmann G
    Am J Kidney Dis; 2005 Sep; 46(3):520-8. PubMed ID: 16129215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
    Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
    Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis.
    Kovesdy CP; Anderson JE
    Semin Dial; 2007; 20(6):566-9. PubMed ID: 17991206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipids, cardiovascular risk factors].
    Delahaye F; de Gevigney G
    Nephrologie; 2000; 21(7):319-21. PubMed ID: 11200599
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for vascular complications in patients on peritoneal dialysis.
    Arima H; Nakamoto H; Okada S; Inoue T; Kobayashi K; Shoda J; Ikeda N; Kanno Y; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():192-7. PubMed ID: 16983968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    Geriatr Nurs; 2006; 27(3):142-8. PubMed ID: 16757384
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic kidney disease as a cardiovascular risk factor.
    Best PJ; Holmes DR
    Am Heart J; 2003 Mar; 145(3):383-6. PubMed ID: 12660658
    [No Abstract]   [Full Text] [Related]  

  • 19. [What should nephrologists know about cardiac illnesses in patients on peritoneal dialysis?].
    Alonso Gómez AM
    Nefrologia; 2008; 28 Suppl 6():105-12. PubMed ID: 18957020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors and cardiovascular disease in uremic patients].
    Valdés F; Morales JM
    Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.